Pharma industry is ready to embrace technology platforms with a keen focus on automation in manufacturing and digital health investment.
The company continued to maintain clear FDA status across its plants and has received 12 ANDA approvals during 9MFY21
The company has concluded our acquisition of Richcore Lifesciences on 20th Jan 2021.
Their feedback and the consequent changes in software/protocols based on those inputs were deliberated upon.
Subscribe To Our Newsletter & Stay Updated
